Tamara Rusman

6PUBLICATIONS
36CO-AUTHORS
Rheumatology and arthritisPeripheral nervous systemOther education not elsewhere classifiedMedical infection agents (incl. prions)Women's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 01, 2022
One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment.

Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis

|May 11, 2022
Does a short course of etanercept influence disease progression and radiographic changes in patients suspected of non-radiographic axial spondyloarthritis? Three -years follow- up of a placebo-controlled trial.

T Rusman, Mac van der Weijden, M T Nurmohamed

|Jun 28, 2021
Reply.

Tamara Rusman, Mignon A C van der Weijden, Michael T Nurmohamed

|Dec 05, 2020
Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six-Month Results of a Placebo-Controlled Trial.

Tamara Rusman, Mignon A C van der Weijden, Michael T Nurmohamed

|Jan 10, 2020
Presence of active MRI lesions in patients suspected of non-radiographic axial spondyloarthritis with high disease activity and chance at conversion after a 6-month follow-up period.

Tamara Rusman, Marie-Luise B John, Mignon A C van der Weijden

|Apr 04, 2018
Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice.

Tamara Rusman, Saskia Ten Wolde, Sjoerd M Euser

Pageof 1

Frequent Collaborators

4 joint publications

Irene van der Horst-Bruinsma

2 joint publications

Mike T Nurmohamed

1 joint publications

Rbm Landewé

1 joint publications

P M Bet